3. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta Francesco (2012) · Journal of the neurological sciences · n=91
Randomized controlled trial View details
4. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment.
Amenta Francesco (2014) · Journal of Alzheimer's disease : JAD · n=113
Randomized controlled trial View details
5. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.
McEvoy Joseph (2013) · PloS one · n=20
Randomized controlled trial View details
6. [Centrally acting cholinomimetics in the complex therapy of progressive glaucomatous optic neuropathy].
Erichev V P (2016) · Vestnik oftalmologii · n=240
Randomized controlled trial View details
7. Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults.
Kawamura Takashi (2012) · Nutrition (Burbank, Los Angeles County, Calif.)
Randomized controlled trial View details
8. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength.
Bellar David (2015) · Journal of the International Society of Sports Nutrition
Randomized controlled trial View details
9. Alpha-Glycerylphosphorylcholine Increases Motivation in Healthy Volunteers: A Single-Blind, Randomized, Placebo-Controlled Human Study.
Tamura Yasuhisa (2021) · Nutrients
Randomized controlled trial View details
10. Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period.
McEntyre Christopher J (2015) · Annals of clinical biochemistry
Randomized controlled trial View details